Correlation between target motion and the dosimetric variance of breast and organ at risk during whole breast radiotherapy using 4DCT by unknown
Wang et al. Radiation Oncology 2013, 8:111
http://www.ro-journal.com/content/8/1/111RESEARCH Open AccessCorrelation between target motion and the
dosimetric variance of breast and organ at risk
during whole breast radiotherapy using 4DCT
Wei Wang1, Jian Bin Li1*, Hong Guang Hu2, Feng Xiang Li1, Min Xu1, Tao Sun2 and Jie Lu2Abstract
Purpose: The purpose of this study was to explore the correlation between the respiration-induced target motion
and volume variation with the dosimetric variance on breast and organ at risk (OAR) during free breathing.
Methods and materials: After breast-conserving surgery, seventeen patients underwent respiration-synchronized
4DCT simulation scans during free breathing. Treatment planning was constructed using the end inspiration scan,
then copied and applied to the other phases and the dose distribution was calculated separately to evaluate the
dose-volume histograms (DVH) parameters for the planning target volume (PTV), ipsilateral lung and heart.
Results: During free breathing, the treated breast motion vector was 2.09 ± 0.74 mm, and the volume variation was
3.05 ± 0.94%. There was no correlation between the breast volume and target/OAR dosimetric variation
(|r| = 0.39 ~ 0.48). In the anteroposterior, superoinferior and vector directions, breast movement correlated well with
the mean PTV dose, conformal index, and the lung volume receiving high dose (|r| = 0.651-0.975); in the
superoinferior and vector directions, breast displacement only correlated with the heart volume receiving >5
Gy (V5) (r = −0.795, 0.687). The lung volume and the lung volume receiving high dose correlated reasonably well
(r = 0.655 ~ 0.882), and a correlation only existed between heart volume and V5 (r = −0.701).
Conclusion: Target movement correlated well with the target/OAR dosimetric variation in certain directions,
indicating that whole breast IMRT assisted by breathing control or respiratory-adapted gated treatment promotes
the accuracy of dose delivery during radiotherapy. During free breathing, the effect of breast volume variation can
be ignored in whole breast IMRT.Introduction
Breast conservation therapy is accepted as the standard
treatment and the preferred treatment for early-stage
breast carcinoma, and breast radiotherapy after breast-
conserving lumpectomy is an important part of breast
conservation therapy. Postoperative whole breast radio-
therapy (WBRT) results in the reduction of local and re-
gional recurrence and also contributes to improvements
in overall survival [1]. Compared with conventional radio-
therapy, intensity modulated radiotherapy (IMRT) de-
creases acute toxicity and allows superior cosmetic
outcome [2,3], thus, IMRT is a widely accepted alternative
for patients undergoing large breast-conserving surgery.* Correspondence: lijianbin@msn.com
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reproduction in any medium, provided the orThere are several factors that lead to uncertainties in
target position between treatment and planning com-
puted tomography scanning, such as setup error, breath-
ing motion, and breast deformation. However, in recent
years, with the development of sophisticated image-
guided online and offline setup verification and correc-
tion techniques, such as the electric portal imaging
device (EPID) and cone-beam CT (CBCT), the inter-
fraction setup error has been significantly reduced dur-
ing delivery of irradiation in breast cancer patients [4-7].
Although the intrafractional breathing motion is usually
only a few millimeters [8-10], respiratory-induced move-
ment during free breathing has recently become the
focus of radiotherapy research [8,9,11,12]. A number of
studies have shown that the dosimetric impact of re-
spiratory motion was clinically insignificant during free
breathing [8,9]. However, several investigations reportedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and breathing control reduced the uncertainty in the tar-
get movement resulting from respiration [11,12]. Various
techniques for postoperative WBRT have been used in
different studies. In our study, the tangential field tech-
nique with static multileaf collimator segments (SMLC)
IMRT was used after breast-conserving surgery.
Currently, there are few studies using four dimensional
computed tomography (4DCT) both to analyze the
respiration-induced target movement and volume change
during WBRT, and to correlate these with the resulting
dosimetric impact. The main purposes of this study were
(1) to investigate the uncertainty of the treated breast mo-
tion and volume variation induced by respiration during
free breathing using 4DCT, (2) to study the resulting dosi-
metric impact during the whole breathing cycle, and (3)
correlate the magnitude of respiration-induced (1) with
(2). On the basis of this correlation, we propose the treat-
ment phases for respiratory-gated radiation therapy to
achieve a high dose conformity and homogeneity around
the target while sparing normal tissues.
Methods and materials
Patient selection and instruction
Seventeen early-stage breast cancer patients who had
undergone breast-conserving surgery and were poten-
tially eligible for adjuvant WBRT were enrolled in this
study. Patients with restricted arm movements after sur-
gery and poor pulmonary function were excluded. Ten
of these 17 patients had right-sided breast cancer, and
the remaining seven had left-sided breast cancer. Writ-
ten informed consent was obtained from all patients and
this study was approved by the institutional research
ethics board of Shandong Cancer Hospital.
4DCT data acquisition
Patients were immobilized in the supine position on a
breast board with both arms raised over the head and
positioned on the arm support device. A knee support
was placed under the knees to fix the position and im-
prove patient comfort.
The free breathing 4DCT scans were acquired on
a 16-slice CT scanner (Philips Brilliance Bores CT,
Netherlands). Three laser alignment lines were marked
on the patient before CT acquisition. The respiratory
signal was recorded with the Varian real-time position
management (RPM) System (Varian Medical Systems,
Palo Alto, CA, USA), by measuring the displacement of
the infrared markers placed on the epigastric region of
the patient’s abdomen. GE Advantage 4D software (GE
Healthcare, Waukesha, WI, USA) was used to sort the
reconstructed 4DCT images into ten respiratory phases
labeled as 0-90% on the basis of triggered signals. Phase
0% denotes the maximum end inspiration (EI) and phase50% denotes the maximum end expiration (EE). The
4DCT images were reconstructed using a thickness of
2 mm and then transferred to the Eclipse treatment
planning system (TPS) (Eclipse 8.6, Varian Medical Sys-
tems, Palo Alto, CA, USA) for structure delineation and
treatment planning generation.
Treatment planning and dosimetric evaluation
The treated breast (CTV), ipsilateral lung (IPSL), and
heart were delineated on the 10 phases of the 4DCT
data sets. CTV was defined based on the visible glandu-
lar breast tissue seen on the CT images, using anatomic
references. In addition, the maximal displacements in
the lateral (LR), anteroposterior (AP) and superoinferior
(SI) directions were derived from the positions of the
centre of the mass. The planning target volume (PTV)
was generated using a 5 mm margin around the CTV
and shrunk by 5 mm below the skin surface.
Treatment planning was established at the EI phase,
using the tangential field technique with static multileaf
collimator segments (SMLC) IMRT irradiating the whole
breast. The prescription dose was 50 Gy at 2 Gy per
fraction to the PTV using 6 MV photon beams. The cri-
teria of SMLC-IMRT planning were to ensure at least
95% of the PTV received the prescription dose, the seg-
mented MLCs were manipulated to shield the areas of
the PTV receiving doses > 103% of the prescription dose.
The dose delivered to organs at risk, such as the IPSL
and heart were maintained within normal accepted tol-
erances. The volume of the ipsilateral lung receiving
20 Gy was <25%, and the volume of the heart receiving
30 Gy was <10%.
Treatment planning was copied and applied to each
phase of the 4DCT scan, with the gantry angles, monitor
units delivered per beam, collimator angles, and primary
field size exactly the same for all respiratory phases. The
dose distribution was calculated separately in all phases.
CTV spatial motion vector ⇀v
   was calculated as
j⇀v j ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
LR2 þ AP2 þ SI2;
q
in which LR, AP, SI represent the CTV displacements in
the lateral, anteroposterior and superoinferior directions.
For the PTV, the following parameters were evaluated:
the mean dose (Dmean), homogeneity index (HI), and




in which D2 and D98 represent the dose to 2% and 98%
of the target volume, respectively, and DT is the pre-
scription dose [13]. CI was defined as
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where PTVref represents the volume of PTV that is cov-
ered by the reference dose, VPTV is defined as the plan-
ning target volume and Vref represents the volume
enclosed by the prescribed isodose [14,15]. The volumes
receiving more than 5, 10, 20, 30, 40, 50 Gy (V5, V10,
V20, V30, V40, V50) and Dmean were acquired for the IPSL
and heart.Statistical analysis
Statistical analysis was performed using the SPSS statis-
tical analysis software package. The Pearson correlation
test was used to study the relationship between the mo-
tion and volume variation in CTV and PTV/OARs pa-
rameters during free breathing. We regarded a p value
<0.05 as statistically significant.Results
Target motion and volume change
In a comparison of the different 4DCT phases, the treated
breast centroid movement reached 1.03 ± 0.48 mm, 0.95 ±
0.36 mm, and 1.38 ± 0.85 mm in the LR, AP, and SI direc-
tions, respectively. The CTV showed the greater move-
ment in the SI direction compared with the LR and AP
directions. The spatial motion vector was 2.09 ± 0.74 mm.
Therefore, the relatively large intrafraction motion was
scattered asymmetrically. The CTV volume variation dur-
ing the whole breathing cycle was 3.05 ± 0.94% (generally
within 1.59% - 4.91%).Table 1 Correlation between the whole respiratory cycle targ
PTV
Dmean HI CI V5
LR r −0.471 0.289 0.085 0.607
P 0.170 0.419 0.814 0.062
AP r −0.855 0.594 −0.820 −0.099 −
P 0.002 0.070 0.003 0.786
SI r 0.693 −0.545 0.791 0.086
P 0.026 0.104 0.006 0.812
Vector r −0.651 0.518 −0.846 −0.161 −
P 0.041 0.125 0.002 0.657
volume r −0.200 0.250 0.316 0.459
P 0.579 0.485 0.374 0.182
Abbreviations: PTV planning target volume; IPSL ipsilateral lung; LR lateral; AP antero
mean dose.Influence of breast motion on dose
During free breathing, the homogeneity index (HI) of
PTV variation was a median of 2.02% (range 0.68% -
9.79%), and the correlation between breast motion and
HI revealed no statistical significance (Table 1). While
the variation in conformal index (CI) during a free
breathing cycle was a median of 2.60% (range 0.79% -
10.84%), statistically significant correlations were found
between the breast spatial motion and CI, except in the
LR direction (Table 1). The mean PTV dose, HI, and CI
did not show a statistically significant correlation with
the treated breast volume variance during free breathing.
Table 1 shows the correlation between the treated
breast movement and the lung dose-volume histo-
grams (DVH) parameters during the respiration cycle.
The volumes of the IPSL receiving more than 20 Gy
(V20, V30, V40, V50) and the Dmean all correlated well
with the treated breast motion in the AP and SI di-
rections, and a statistically significant inverse correl-
ation was found for the motion vector. This meant
that SMLC-IMRT was sensitive to breast movement
induced by breathing motion. There were no mean-
ingful correlations between the dosimetric parameters
and changes in the breast volume. In other words,
during radiation therapy, breast motion has a signifi-
cant effect on the IPSL dosimetric parameters rather
than the breast volume change.
In the 7 left-sided breast cancer patients, the correl-
ation coefficients between the dosimetric parameters of
the heart and breast motion, and the changes in breast
volume are shown in Table 2. As shown in Table 2, only
V5 showed a good correlation with motion in the AP
direction and the motion vector throughout the respira-
tory cycle. The heart has its intrinsic rhythm and out of
sync with the breathing motion.et motion/volume and PTV and IPSL parameters
IPSL
V10 V20 V30 V40 V50 Dmean
0.453 0.297 0.161 0.125 0.067 −0.307
0.188 0.405 0.656 0.731 0.854 0.301
0.653 −0.857 −0.897 −0.951 −0.975 0.798
0.041 0.002 0.000 0.000 0.000 0.006
0.575 0.752 0.777 0.862 0.884 0.804
0.082 0.012 0.008 0.001 0.001 0.005
0.651 −0.808 −0.824 −0.891 −0.905 −0.779
0.042 0.005 0.003 0.001 0.000 0.008
0.455 0.416 0.346 0.352 0.354 0.480
0.186 0.232 0.327 0.319 0.315 0.161
posterior; SI superoinferior; Vx volume receiving more than x Gy; Dmean the
Table 2 Correlation between the whole respiratory cycle
target motion/volume and heart parameters for left-
sided patients
V5 V10 V20 V30 V40 V50 Dmean
LR r 0.170 0.326 0.394 0.412 0.481 0.274 0.393
P 0.638 0.358 0.236 0.236 0.159 0.444 0.377
AP r 0.523 0.356 0.274 0.296 0.188 −0.397 −0.338
P 0.121 0.313 0.444 0.406 0.603 0.256 0.339
SI r −0.795 −0.590 −0.44 −0.446 −0.286 0.483 0.496
P 0.006 0.073 0.203 0.196 0.424 0.157 0.145
Vector r 0.687 0.470 0.324 0.327 0.174 −0.509 −0.445
P 0.028 0.170 0.361 0.356 0.632 0.133 0.198
volume r −0.390 −0.287 −0.196 −0.166 −0.104 0.252 −0.236
P 0.265 0.421 0.588 0.647 0.775 0.482 0.512
Abbreviations: LR lateral; AP anteroposterior; SI superoinferior; Vx volume
receiving more than x Gy; Dmean the mean dose.
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From Figure 1, it can be seen that the lung volume vari-
ation fell within the respiratory rationale, while an ir-
regularity in the respiratory cycle led to changes in the
heart volume: an uneven curve instead of a sine curve.
The results of Figure 1 shows the principle of a 4DCT:
the lung volume changes as a function of the breathing
phase. The heart movement is much faster than the res-
piration triggered CT. So the change of the heart volume
cannot be assessed with a respiration gated CT. Table 1
shows that the changes in the ipsilateral lung volume
correlated well with the lung volume receiving more
than 20, 30, 40, 50 Gy (V20, V30, V40, V50) (r = 0.655,
0.728, 0.822, 0.882). The evaluation of DVHs for the
heart was performed in 7 patients with left-sided breast
cancer. Preliminary data from these patients indicated
that the heart volume change only correlated with theFigure 1 The changes in the ipslateral lung (left) and heart volume (rheart volume receiving more than 5 Gy (V5) (r = −0.701,
Table 2).
Discussion
Many studies have been performed using various tech-
niques to investigate the treated breast movement by
implementing respiratory management methods in radi-
ation delivery such as EPID and 4D medical imaging
[9,16]. Differences were observed to exist between these
different methods. In our investigation, we concluded
that peak-to-peak respiration induced the treated breast
to move in the SI direction and reached a maximal value
of 1.38 ± 0.85 mm, and the motion vector was 2.09 ±
0.74 mm. Other authors also investigated the motion
characteristics of the treated breast using 4DCT and
showed similar results. For example, Qi et al. [9] demon-
strated that the maximum centroid movement ranged
from 1.1-3.9 mm for the ipsilateral breast during free
breathing. The motion extent measured in our study
was also consistent with Richter et al. [8], who measured
the motion amplitude of the breast motion in the 4D
CT images. They reported that the motion amplitude of
the breast motion was between 0.2 mm and 3.8 mm,
1.8 mm on average. Strydhorst et al. [17] reported that
for breast, the average maximum motion of the external
contour was 1.3 ± 1.6 mm. Thus, our data are consistent
with the results of their study. Our study addressed
whether this small intrafraction motion amplitude of the
treated breast resulted in a significant variance in the
dose delivered to the PTV and OARs. And intratreat-
ment target volume variation was also investigated
throughout the whole respiratory cycle.
During the respiratory cycle, the variation in the HI
showed little dependence on the target displacement,
while the patients breathed freely. This parameter didight) in successive 4DCT phases during free breathing.
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volume. However, the variance in the HI among all 17
patients studied ranged from 0.68% to 9.79%, which
indicated that the deterioration in dose distributions
induced by respiratory motion varied substantially be-
tween and within patients. Patients were immobilized in
the supine position on a sloping breast board. As a
non-rigid tissue, the breast was deformed due to the
effects of gravity and breathing patterns, and the
three dimensional movement correlations were asym-
metrical. Thus, throughout the respiratory cycle a sta-
tistically significant inverse correlation was found
between the motion vector and the mean PTV dose
and CI, while there was no correlation with breast
motion in the LR directions. The maximum variance
of the CI reached 10.84% in our study, thus,
respiration-induced breast motion resulted in altered
dose distributions, and was associated with a small
amplitude in target motion bearing a higher risk for
lower PTV coverage. This finding indicated that
although the motion amplitude of the treated breast
in the 4DCT studies was small, breathing control and
real time tumor tracking might improve target cover-
age for whole breast irradiation and have the poten-
tial to decrease the PTV dose heterogeneity.
The anatomical movement within the planned radi-
ation field induced by breathing motion can lead to a
decrease in target coverage and normal tissue sparing,
resulting in an increased risk of treatment failure and
normal tissue complication probability (NTCP) [18].
Acute lung pneumonia and late lung fibrosis depends on
the lung volume irradiated during WBRT [19,20]. Ana-
lysis of the treated breast movement and the volume
variation of the ipsilateral lung for these 17 patients
showed a strong correlation with the high dose delivered
to the lung during the respiratory cycle. The findings in
our study confirmed that the deterioration in lung dose
during free breathing were also relatively insensitive to
breast motion and thorax expansion. This was consistent
with a study by Cao et al. [21], where a linear model was
developed to relate the dosimetric coverage difference
introduced by respiration with the motion information.
Based on their studies, they recommend that beamlet
IMRT with motion of a medial marker >0.6 cm is not
used for whole-breast radiotherapy unless the use of res-
piration control is considered. We further researched
the relationship between lung volume variation and the
dosimetric coverage. And found that during the respira-
tory cycle, patients with smaller lung volume in end
expiration phases were associated with decreased dose
to the IPSL. Hence, for WBRT, breathing control or
respiratory-adapted gated treatment may spare the IPSL
compared with the conventional non-gated plan in a
subset of patients with large lung volume variations, andrespiration gating may be more precise if performed at
the EE phase. From the results of these 17 patients, it
is not possible to propose guidelines for the selection
of patients suitable for advanced techniques such as
active breathing control (ABC) and real time tumor
tracking. However, we suggest that breathing control,
real time tumor tracking and image-guided radiother-
apy may be clinically significant for whole breast
IMRT in addition to what was achieved by the tech-
nique described here.
Radiotherapy for left breast cancer is associated with
an increased risk of acute or chronic cardiotoxicity, such
as ischemic heart disease, pericarditis, and myocardial
infarction, long after treatment. The data from Figure 1
shows that the heart volume variation did not follow the
respiratory patterns during a normal free breathing
cycle, resulting in a higher likelihood of intrinsic cardiac
contractions. The technique of SMLC-IMRT combined
with the limited heart volume included in the radiation
fields, showed that breast motion did not significantly
correlate with dose distribution within the heart during
WBRT. Using 4DCT images, Qi et al. [12] demonstrated
that the distance from the left ascending aorta to a fixed
line (DLAD) and the maximum heart depth (MHD)
changed up to 9 and 11 mm, respectively, and were posi-
tively correlated with mean heart dose and heart dose
volume. The differences between the results in our study
and Qi’s investigation might be due to differences in
radiotherapy technique. We treated the whole breast
with SMLC-IMRT, while Qi et al. used conventional 3D
planning with tangential beams for whole breast and a
boost to the lumpectomy bed PTV. Although the
respiration-induced breast movements played only a
minimal part in the heart dosimetric variance, heart
movement should be used independently as a conside-
ration for the respiratory gating procedure before
treatment planning. Hence, respiratory-adapted gated
treatment or breathing control may spare the heart com-
pared with the conventional plan.
Our study focused on the analysis of breathing
motion and volume change, target delineation errors
were not considered. However, this uncertainty may
affect the accuracy of the dose distribution and dose
homogeneity in the treated breast, therefore, all tar-
gets and OARs should be consistently delineated by
one radiotherapist using uniform criteria to decrease
geometrical uncertainties [22]. During the respiratory
cycle, mean breast volume change was small (<4%),
and the correlations with PTV and OARs dose vari-
ation were not significant. Our work has shown that
intrafractional changes in the breast volume were
generally clinically insignificant and did not greatly
influence the dose distribution, therefore can be
ignored during radiotherapy.
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The treated breast volume change during respiration can
be ignored for whole breast forward intensity modulated
radiotherapy during free breathing. The respiratory-
induced motion of the breast is usually only a few milli-
meters, but may also decrease target coverage and the
resulting dosimetric impact. This indicates that small
breathing motions can lead to a change in the dose dis-
tributions, and 4D treatment planning and/or breathing
control for tangential field breast radiotherapy should
improve the accuracy of dose delivery.
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